Strata Critical Medical, Inc. (SRTA) Q2 FY26 Earnings Call

$285-$295 million revenue guidance and $33-$35 million adjusted EBITDA guidance increased for 2026.

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-08-04
Length30 minutes
EPS$-0.01
EPS consensus$-0.01
Revenue$72.5M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All SRTA earnings ยท Back to SRTA overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.